NEW HAVEN, Conn., Sept. 22, 2011 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Michael D. Kishbauch, President and Chief Executive Officer, will provide a corporate update at the upcoming Sixth Annual JMP Securities Healthcare Conference on Wednesday, September 28, 2011 at 10:00 a.m. EDT at the St. Regis New York Hotel, New York, NY.
